News summaryBenzingaNov 2, 2026, 05:48 PM
Abbott Touts Favorable Outcomes In Cardiovascular Device Trials - Abbott Laboratories (NYSE:ABT) - Benzinga
ABTequity_markets
Abbott Touts Favorable Outcomes In Cardiovascular Device Trials - Abbott Laboratories (NYSE:ABT) - Benzinga(摘要待生成)